YARTEMLEASSIST PATIENT SUPPORT PROGRAM
LIVE

Serial Number

97462726

Owner

Omeros Corporation

Attorney

Kelley B. Harrington

Filing Date

Jun 16, 2022

Add to watchlist:

No watchlists yet
View on USPTO

YARTEMLEASSIST PATIENT SUPPORT PROGRAM Trademark

Serial Number: 97462726 • Registration: 8206166

YARTEMLEASSIST PATIENT SUPPORT PROGRAM is a trademark filed by Omeros Corporation on June 16, 2022. The trademark is classified under Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Omeros Corporation (107 trademarks)

Attn: Marcia S. Kelbon
Seattle, WA 98101

Entity Type: 03

Trademark Details

Filing Date

June 16, 2022

Registration Date

April 7, 2026

Published for Opposition

December 20, 2022

Goods & Services

Educational services, namely, conducting educational programs in the fields of endothelial diseases and disorders, renal diseases, transplant complications, hematological, neurological, immunological and inflammation-related disease and disorders and treatment and patient support options for these conditions

Printed publications in the nature of brochures, pamphlets, newsletters, written articles and guidebooks in the field of medical information and patient support

Providing a website featuring financial information regarding medical benefits and reimbursements available for medical expenses related thereto; insurance services, namely, benefits verification in the nature of insurance claims administration; and providing online information and financial assistance with insurance benefits and coverage for health care providers and patients in the field of endothelial diseases and disorders, renal diseases, transplant complications, hematological, neurological, immunological and inflammation-related disease and disorders

Promoting awareness of patient support offerings for endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders; business administration of reimbursement and medical benefit information for endothelial diseases and disorders, renal diseases, transplant complications, hematological, neurological, immunological and inflammation-related disease and disorders and their treatment; and business administrative services for medical referrals

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 7, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 7, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 13, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 13, 2026 CNPR
EXAMINER'S AMENDMENT ENTERED
Mar 13, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 13, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 13, 2026 GNEA
SU-EXAMINER'S AMENDMENT WRITTEN
Mar 13, 2026 SNEA
DATA MODIFICATION COMPLETED
Mar 2, 2026 DMCC
ASSIGNED TO LIE
Feb 24, 2026 ALIE
STATEMENT OF USE PROCESSING COMPLETE
Feb 19, 2026 SUPC
USE AMENDMENT FILED
Feb 11, 2026 IUAF
TEAS STATEMENT OF USE RECEIVED
Feb 11, 2026 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 18, 2025 EXRA
SOU EXTENSION 5 GRANTED
Dec 18, 2025 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 18, 2025 AITU
SOU EXTENSION 5 FILED
Jul 29, 2025 EXT5
SOU TEAS EXTENSION RECEIVED
Jul 29, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 4, 2025 EXRA
SOU EXTENSION 4 GRANTED
Jan 16, 2025 EX4G
SOU EXTENSION 4 FILED
Jan 16, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Jan 16, 2025 EEXT
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 14, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 14, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 14, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 14, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 14, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 14, 2024 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 21, 2024 EXRA
SOU EXTENSION 3 GRANTED
Jun 21, 2024 EX3G
SOU EXTENSION 3 FILED
Jun 21, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 21, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 26, 2024 EXRA
SOU EXTENSION 2 GRANTED
Jan 24, 2024 EX2G
SOU EXTENSION 2 FILED
Jan 24, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 24, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 12, 2023 EXRA
SOU EXTENSION 1 GRANTED
Jul 10, 2023 EX1G
SOU EXTENSION 1 FILED
Jul 10, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 10, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 14, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 20, 2022 NPUB
PUBLISHED FOR OPPOSITION
Dec 20, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 30, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 14, 2022 CNSA
ASSIGNED TO EXAMINER
Nov 8, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 2, 2022 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 1, 2022 NWOS
NEW APPLICATION ENTERED
Jun 20, 2022 NWAP